Seacross Pharmaceuticals | DMFs | US Drug Master File (DMF) Details | Pharmacompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

SEACROSS PHARMACEUTICALS
USDMF

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

Contact Supplier

pharmacompass-1-m-2026-04-20

As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

Contact Supplier

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

pharmacompass-2-m-2026-04-20

SEACROSS PHARMACEUTICALS

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow

ACTIVE PHARMA INGREDIENTS

6 All APIs, 6 USDMF

6 All APIs
6 USDMF

FINISHED DOSAGE FORMULATIONS

68 FDF Dossiers, 68 Europe

68 FDF Dossiers
68 Europe

INSPECTIONS & REGISTRATIONS

1 EDQM

1 EDQM

Xls

Filters

Reset all filters

Filters

FILTER :

filter Subject Reset all filters

6 All

01 1BORTEZOMIB

02 1CALCIUM LEVOFOLINATE

03 1CARFILZOMIB

04 1ETOPOSIDE

05 1METHOTREXATE

06 1THIOTEPA

filter Holder Reset all filters

6 All

01 6SEACROSS PHARMA USA INC

filter Country Reset all filters

6 All

01 6United Kingdom

filter Status Reset all filters

6 All

01 3Active

02 3Inactive

GDUFA DMF Review Reset all filters

6 All

01 6Blank

List of Suppliers

Supplier Virtual Booth

price-trend

01

Bortezomib

RDD

Not Confirmed

Bortezomib

RDD

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SEACROSS PHARMACEUTICALS

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 39374

Submission : 2024-01-09

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

02

Calcium Levofolinate

RDD

Not Confirmed

Calcium Levofolinate

RDD

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SEACROSS PHARMACEUTICALS

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38433

Submission : 2023-05-31

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

03

Carfilzomib

RDD

Not Confirmed

Carfilzomib

RDD

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SEACROSS PHARMACEUTICALS

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38169

Submission : 2023-04-03

Status : Inactive

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

04

Etoposide

RDD

Not Confirmed

Etoposide

RDD

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SEACROSS PHARMACEUTICALS

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38779

Submission : 2023-09-01

Status : Inactive

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

05

Methotrexate

RDD

Not Confirmed

Methotrexate

RDD

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SEACROSS PHARMACEUTICALS

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38314

Submission : 2023-04-23

Status : Inactive

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

06

Thiotepa

RDD

Not Confirmed

Thiotepa

RDD

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

SEACROSS PHARMACEUTICALS

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 38406

Submission : 2023-08-15

Status : Active

Type : II

Product
Web Link

Stock Recap
#PipelineProspector

Contact Seacross Pharmaceuticals and get a quotation

Seacross Pharmaceuticals is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find Bortezomib bulk with DMF offered by Seacross Pharmaceuticals

Find Levoleucovorin Calcium bulk with DMF offered by Seacross Pharmaceuticals

Find Thiotepa bulk with DMF offered by Seacross Pharmaceuticals

Find Carfilzomib bulk offered by Seacross Pharmaceuticals

Find Etoposide bulk offered by Seacross Pharmaceuticals

Find Methotrexate bulk offered by Seacross Pharmaceuticals

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.